These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26265409)

  • 1. Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis.
    Iversen LV; Ullman S; Østergaard O; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
    BMC Musculoskelet Disord; 2015 Aug; 16():191. PubMed ID: 26265409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
    Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
    Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis.
    Michalska-Jakubus M; Kowal-Bielecka O; Smith V; Cutolo M; Krasowska D
    Microvasc Res; 2017 Mar; 110():24-31. PubMed ID: 27889559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
    Yalçinkaya Y; Çinar S; Artim-Esen B; Kamali S; Öcal L; Deniz G; Inanç M
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):110-114. PubMed ID: 27749243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum levels of fractalkine and mobilisation of CD34
    Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
    Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis.
    Ateş A; Kinikli G; Turgay M; Duman M
    Scand J Immunol; 2004 Mar; 59(3):315-20. PubMed ID: 15030584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation.
    Lau YC; Xiong Q; Blann AD; Lip GY
    J Thromb Thrombolysis; 2017 Jan; 43(1):18-23. PubMed ID: 27671694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation.
    Macko RF; Gelber AC; Young BA; Lowitt MH; White B; Wigley FM; Goldblum SE
    J Rheumatol; 2002 Dec; 29(12):2565-70. PubMed ID: 12465153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet Phagocytosis via P-selectin Glycoprotein Ligand 1 and Accumulation of Microparticles in Systemic Sclerosis.
    Manfredi AA; Ramirez GA; Godino C; Capobianco A; Monno A; Franchini S; Tombetti E; Corradetti S; Distler JHW; Bianchi ME; Rovere-Querini P; Maugeri N
    Arthritis Rheumatol; 2022 Feb; 74(2):318-328. PubMed ID: 34279048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis.
    Kollert F; Christoph S; Probst C; Budweiser S; Bannert B; Binder M; Sehnert B; Voll RE; Warnatz K; Zissel G; Walker UA; Prasse A; Saalbach A
    Arthritis Care Res (Hoboken); 2013 Feb; 65(2):281-7. PubMed ID: 22807289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Clin Rheumatol; 2005 Apr; 24(2):111-6. PubMed ID: 15349798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis.
    Guiducci S; Distler JH; Jüngel A; Huscher D; Huber LC; Michel BA; Gay RE; Pisetsky DS; Gay S; Matucci-Cerinic M; Distler O
    Arthritis Rheum; 2008 Sep; 58(9):2845-53. PubMed ID: 18759303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.
    Apras S; Ertenli I; Ozbalkan Z; Kiraz S; Ozturk MA; Haznedaroglu IC; Cobankara V; Pay S; Calguneri M
    Arthritis Rheum; 2003 Aug; 48(8):2256-61. PubMed ID: 12905480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
    Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
    Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.
    Hasegawa M; Asano Y; Endo H; Fujimoto M; Goto D; Ihn H; Inoue K; Ishikawa O; Kawaguchi Y; Kuwana M; Ogawa F; Takahashi H; Tanaka S; Sato S; Takehara K
    PLoS One; 2014; 9(2):e88150. PubMed ID: 24516598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
    Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases.
    Sfikakis PP; Charalambopoulos D; Vaiopoulos G; Mavrikakis M
    Clin Rheumatol; 1999; 18(1):28-32. PubMed ID: 10088945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.
    Nielsen CT; Østergaard O; Johnsen C; Jacobsen S; Heegaard NH
    Arthritis Rheum; 2011 Oct; 63(10):3067-77. PubMed ID: 21702008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between cutaneous and pulmonary involvement in systemic sclerosis.
    Morelli S; Barbieri C; Sgreccia A; Ferrante L; Pittoni V; Conti F; Gualdi G; Polettini E; Carlesimo OA; Calvieri S
    J Rheumatol; 1997 Jan; 24(1):81-5. PubMed ID: 9002015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.